CAS 27851-29-2
:[(3R,4S,5S,6R)-3,4,5,6-tetrabenzyloxitetraidropirano-2-il]metanolo
Formula:C34H36O6
InChI:InChI=1/C34H36O6/c35-21-30-31(36-22-26-13-5-1-6-14-26)32(37-23-27-15-7-2-8-16-27)33(38-24-28-17-9-3-10-18-28)34(40-30)39-25-29-19-11-4-12-20-29/h1-20,30-35H,21-25H2/t30?,31-,32+,33+,34-/m1/s1
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 7 prodotti.
Benzyl 2,3,4-Tri-O-benzyl-β-D-glucopyranoside
CAS:Formula:C34H36O6Purezza:min. 95.0 area%(HPLC)Colore e forma:White to Almost white powder to crystalPeso molecolare:540.66β-D-Glucopyranoside, phenylmethyl 2,3,4-tris-O-(phenylmethyl)-
CAS:Formula:C34H36O6Purezza:95%Colore e forma:SolidPeso molecolare:540.6460Benzyl 2,3,4-tri-O-benzyl-β-D-glucopyranoside
CAS:Benzyl 2,3,4-tri-O-benzyl-β-D-glucopyranosideFormula:C34H36O6Purezza:>98%Peso molecolare:540.646041,2,3,4-Tetra-O-benzyl-β-D-glucopyranoside
CAS:1,2,3,4-Tetra-O-benzyl-β-D-glucopyranoside is a prodrug that becomes active after acetylation. It is an endogenous compound that has been shown to inhibit the synthesis of myelin and lipid peroxidation in rat brains. This drug has also been found to be effective in the treatment of amyotrophic lateral sclerosis (ALS). 1,2,3,4-Tetra-O-benzyl-β-D-glucopyranoside is unmodified and does not have any side effects on the nervous system. It can be used for the treatment of Parkinson's disease when combined with levodopa.Formula:C34H36O6Purezza:Min. 95%Colore e forma:White Off-White PowderPeso molecolare:540.65 g/molBenzyl 2,3,4-Tri-O-benzyl-β-D-glucopyranoside
CAS:Prodotto controllatoApplications Benzyl 2,3,4-Tri-O-benzyl-β-D-glucopyranoside (cas# 27851-29-2) is a compound useful in organic synthesis.
References Wakao, M., et al.: Bioorg. Med. Chem. Lett., 18, 2499 (2008),Formula:C34H36O6Colore e forma:NeatPeso molecolare:540.65






